Oravig Articles
BioAlliance Pharma pursues development plan for Loramyc in Japan through partner Sosei
13 March 2013
BioAlliance says partner Vestiq debuts Oravig in USA
8 January 2013
US FDA approves Strativa’s Oravig, triggering a $20 million milestone for France’s BioAlliance; Agency could put hold on GSK
19 April 2010
Showing 1-4 of 4 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
